Richard Buller
Director/Board Member at CELCUITY INC.
Net worth: 121 918 $ as of 2024-04-29
Profile
Richard E.
Buller is an Independent Director at Celcuity, Inc. He was previously an Independent Director at Rebus Holdings, Inc. and a Director-Oncology Medicine Development Center at GSK Plc.
Prior to that, he was the VP & Head-Clinical Development Oncology at Pfizer Inc. and Vice President-Translational Medicine at Exelixis, Inc. He also worked as a Professor-Gynecologic Oncology at the University of Iowa.
Buller received his undergraduate degree from the University of California, Los Angeles and his doctorate from Baylor College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELCUITY INC.
0.03% | 2024-04-23 | 7,731 ( 0.03% ) | 121 918 $ | 2024-04-29 |
Richard Buller active positions
| Companies | Position | Start |
|---|---|---|
| CELCUITY INC. | Director/Board Member | 2019-12-02 |
Former positions of Richard Buller
| Companies | Position | End |
|---|---|---|
| REBUS HOLDINGS, INC. | Director/Board Member | 2018-02-08 |
| PFIZER, INC. | Corporate Officer/Principal | 2016-06-30 |
| University of Iowa | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Training of Richard Buller
| Baylor College of Medicine | Doctorate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| GSK PLC | Health Technology |
| CELCUITY INC. | Health Technology |
- Stock Market
- Insiders
- Richard Buller
